N2OFF Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Interim Financial Statements
NOTE 1 –GENERAL
| A. | Operations |
N2OFF, Inc. (formerly Save Foods, Inc) (the “Company”) was incorporated on April 1, 2009, under the laws of the State of Delaware.
On November 6, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with N2OFF, Inc., a newly formed Nevada corporation and its wholly owned subsidiary (the “Surviving Corporation”), pursuant to which, on the same date, the Company, as parent in this transaction, merged with and into the Surviving Corporation (the “Reincorporation Merger”). The Reincorporation Merger was approved by the Company’s stockholders on October 2, 2023 and became effective on The Nasdaq Capital Market on November 10, 2023. Upon the consummation of the Reincorporation Merger, the Company ceased its legal existence as a Delaware corporation, and the Surviving Corporation continued Company’s business as the surviving corporation. On February 8, 2024, the Company’s stockholders approved the Company’s name change to “N2OFF, Inc.” which became effective on The Nasdaq Capital Market on March 19, 2024.
On April 27, 2009, the Company acquired from its stockholders 98.48% of the issued and outstanding shares of Save Foods Ltd. including preferred and ordinary shares. Save Foods Ltd. was incorporated in 2004 and commenced its operations in 2005. Save Foods Ltd. develops, produces, and focuses on delivering innovative solutions for the food industry aimed at improving food safety and shelf life of fresh produce.
On March 31, 2023, the Company entered into a securities exchange agreement with Plantify Foods, Inc. (“Plantify”), a Canadian corporation traded on the TSX Venture Exchange (“TSXV”), which focuses on the development and production of “clean-label” plant-based products - see Note 3 below for further information.
On August 29, 2023, the Company entered into an exchange agreement with Yaaran Investments Ltd. and formed an Israeli subsidiary, NTWO OFF Ltd. (“NTWO OFF”) which focus on nitrous oxide (“N2O”), a potent greenhouse gas with significant global warming ramifications (the Company, Save Foods Ltd. and NTWO OFF Ltd collectively, the “Group”)
The Company’s common stock is listed on The Nasdaq Capital Market under the symbol “NITO”.
| B. | Reverse stock split |
On October 4, 2023, following the Company’s 2023 annual meeting of stockholders, the Company filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation in Delaware to effect aone for seven reverse stock split of the Company’s outstanding Common Stock (the “Reverse Stock Split”). The Reverse Stock Split became effective on October 5, 2023.
As a result of the Reverse Stock Split, every seven shares of the Company’s outstanding Common Stock prior to the effect of that amendment were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split and the shares were rounded to the nearest whole number. The authorized capital and par value of the Common Stock remained unchanged.
All shares, stock option and per share information in these consolidated financial statements have been restated to reflect the Reverse Stock Split on a retroactive basis.
NOTE 1 – GENERAL (continue)
| C. | Going concern uncertainty |
Since inception, the Company has incurred significant losses and negative cash flows from operations and has an accumulated deficit of $30 million. The Company has financed its operations mainly through financing by the issuance of the Company’s equity from various investors.
The Company’s management expects that the Company will continue to generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances as of March 31, 2024, management currently is of the opinion that its existing cash will be sufficient to fund operations until the end of the second quarter of 2025. As a result, there is substantial doubt regarding the Company’s ability to continue as a going concern.
Management endeavors to secure sufficient financing through the sale of additional equity securities or capital inflows from strategic partnerships. Additional funds may not be available when the Company needs them, on favorable terms, or at all. If the Company is unsuccessful in securing sufficient financing, it may need to cease operations.
The financial statements do not include adjustments for measurement or presentation of assets and liabilities, which may be required should the Company fail to operate as a going concern.
| D. | Israel – Hamas war |
Because most of the Company’s operations are conducted in Israel and all members of its board of directors, management, as well as a majority of its employees and consultants, including employees of its service providers, are located in Israel, its business and operations are directly affected by economic, political, geopolitical and military conditions affecting Israel.
In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians and soldiers in the southern part of the country. Following the attack, Israel’s security cabinet declared war against Hamas and a military campaign against these terrorist organizations commenced in parallel to their continued rocket and terror attacks. Following the attack by Hamas on Israel’s southern border, Hezbollah in Lebanon also launched missile, rocket, drone and shooting attacks against Israeli military sites, troops and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried out a number of targeted strikes on sites belonging to Hezbollah in Lebanon and Syria. Recently, Iran has directly joined the hostilities against Israel by firing hundreds of drones, ballistic missiles and guided missiles to Israel causing further uncertainty in the region. While currently no damages were registered in Israel from such attack, the situation is developing and could lead to additional wars and hostilities in the Middle East. It is possible that the hostilities with Hezbollah will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank, as well as other hostile countries, will join the hostilities. Such hostilities may include terror and missile attacks. In the event that the Company’s facilities are damaged as a result of hostile actions, or hostilities otherwise disrupt our ongoing operations, its ability to deliver or provide products and services in a timely manner to meet its contractual obligations towards customers and vendors could be materially and adversely affected.
NOTE 1 – GENERAL (continue)
Following the brutal attacks on Israel, the mobilization of army reserves and the government declaring a state of war in October 2023, there was a decrease in Israel’s economic and business activity. The security situation has led, among other things, to a disruption in the supply chain and production, a decrease in the volume of national transportation, and a shortage in manpower due to employees being called for active reserve duty as well as a rise in the exchange rate of foreign currencies in relation to the New Israel Shekel. These events may imply wider macroeconomic indications of a deterioration of Israel’s economic standing, which may have a material adverse effect on the Company and its ability to effectively conduct its business, operations and affairs. Although many of such military reservists have since been released, they may be called up for additional reserve duty, depending on developments in the war in Gaza and along Israel’s other borders. Certain of its employees and consultants in Israel, in addition to employees of its service providers located in Israel, have been called, and additional employees may be called, for service in the current or future wars or other armed conflicts with Hamas as well as the other pending or future armed conflicts in which Israel is or may become engaged, and such persons may be absent for an extended period of time.
Save Foods Ltd has experienced delays in pilots and packaging activities due to the war, as certain packing houses, have halted operations for the time being. Additionally, the Company anticipated engaging additional packing houses to conduct pilots with the Company’s product, but, due to the war, the Company was unable to continue pursuing new collaborations for these pilots, and the Company may not be able to resume any potential collaborations if the current war persists for an extended duration. The Company is unable to predict how long the current conflict will last, as well as the repercussions these delays will have on operations. If the Company is unable to renew pilots or collaborations with local packing houses, the Company’s financial results may be affected.
The Company is continuing to regularly follow developments on the matter and is examining the effects on its operations and the value of its assets.
NOTE 2 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
Basis of presentation
The condensed interim consolidated financial statements included in this Quarterly Report are unaudited. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company’s financial position as of March 31, 2024, and its results of operations for the three months ended March 31, 2024, and 2023, changes in stockholders’ equity for the three months ended March 31, 2024 and 2023, and cash flows for the three months ended March 31, 2024 and 2023. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any other future annual or interim period. These financial statements should be read in conjunction with the audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on April 1, 2024. The Company’s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2023 included in such Form 10-K. Since the date of such financial statements, there have been no changes to the Company’s significant accounting policies.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continue)
Use of Estimates
The preparation of unaudited condensed consolidated interim financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to calculation of fair value of the convertible loan.
Fair value
Fair value of certain of the Company’s financial instruments including cash, accounts payable, accrued expenses, and other accrued liabilities approximate cost because of their short maturities. The Company measures and reports fair value in accordance with Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements” which defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles and expands disclosures about fair value measurements.
Fair value, as defined by ASC 820, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset should reflect its highest and best use by market participants, principal (or most advantageous) markets, and an in-use or an in-exchange valuation premise.
Valuation techniques are generally classified into three categories: (i) the market approach; (ii) the income approach; and (iii) the cost approach. The selection and application of one or more of the techniques may require significant judgment and are primarily dependent upon the characteristics of the asset or liability, and the quality and availability of inputs. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 also provides fair value hierarchy for inputs and resulting measurement as follows:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities; and
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continue)
Fair value (continue)
Level 3: Unobservable inputs for the asset or liability that are supported by little or no market activity, and that are significant to the fair values.
Fair value measurements are required to be disclosed by the level within the fair value hierarchy in which the fair value measurements in their entirety fall. Fair value measurements using significant unobservable inputs (in level 3 measurements) are subject to expanded disclosure requirements including a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), (ii) segregating those gains or losses included in earnings, and (iii) a description of where those gains or losses included in earning are reported in the statement of operations.
The Company’s financial assets that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| US$ | ||||
| Assets: | ||||
| Investment in Plantify | 627,704 | - | - | 627,704 |
| Convertible loan | - | - | 1,111,700 | 1,111,700 |
| Total assets | 627,704 | - | 1,111,700 | 1,739,404 |
The following table presents the changes in fair value of the level 1 assets for the period December 31, 2023 through March 31, 2024:
| Changes in Fair value | |
|---|---|
| US$ | |
| Assets: | |
| Outstanding at December 31, 2023 | 641,561 |
| Changes in fair value | (13,857) |
| Outstanding at March 31, 2024 | 627,704 |
The following table presents the changes in fair value of the level 3 assets for the period December 31, 2023 through March 31, 2024:
| Changes in Fair value | |
|---|---|
| US$ | |
| Assets: | |
| Outstanding at December 31, 2023 | 1,013,900 |
| Changes in fair value | 97,800 |
| Outstanding at March 31, 2024 | 1,111,700 |
NOTE 3 –INVESTMENT IN NONCONSOLIDATED AFFILIATE
On March 31, 2023, the Company entered into a Securities Exchange Agreement with Plantify, pursuant to which each party agreed to issue to the other party 19.99% of its issued and outstanding capital stock (the “Securities Exchange”).
Upon the closing of the Securities Exchange on April 5, 2023, the Company issued 166,340 shares of the its Common Stock to Plantify, which amount represented 19.99% of its outstanding capital stock as of immediately prior to the closing (and 16.66% of the Company’s outstanding capital stock as of immediately following the closing), and Plantify issued 30,004,349 of its common shares to the Company representing 19.99% of Plantify’s outstanding capital stock as of immediately prior to the closing (and 16.66% of Plantify’s outstanding capital stock as of immediately following the closing).
In connection with the Securities Exchange Agreement, the Company and Plantify executed a debenture (the “Debenture”), whereby the Company agreed to lend C$1,500,000 (approximately US$1,124,000) to Plantify. The Debenture accrues interest at a rate of 8% annually and is repayable by Plantify on October 4, 2024. Outstanding principal under the Debenture may be converted, at the Company’s sole discretion, into common shares of Plantify at a price of C$0.05 per share for the first 12 months of the Debenture issuance date and C$0.10 per share thereafter. Accrued interest may be converted at the market price of Plantify’s common shares, subject to TSX Venture Exchange approval at the time of conversion. Plantify executed a general security agreement in the Company’s favor and pledged to the Company the shares of Plantify’ subsidiary, Peas of Bean Ltd.
On September 7, 2023, the Company purchased an additional 55,004,349 common shares of Plantify at a price of C$0.01 per common share (C$404,890), in a rights offering, resulting in an increase of approximately 7% of the Company’s ownership of the issued and outstanding common shares of Plantify. Following the additional acquisition, the Company owns 85,008,698 common shares of Plantify, representing approximately 23% of its issued and outstanding common shares.
The Company determined that it has a significant influence over Plantify and such investment is accounted for under the equity method of accounting. At the initial recognition of the equity investment, the Company elected the fair value option where subsequent changes in fair value are recognized in earnings. If the fair value option is applied to an investment that would otherwise be accounted for under the equity method, the Company applies it to all its financial interests in the same entity (equity and debt, including guarantees) that are eligible items. The equity investment in common shares of Plantify is classified within Level 1 in the fair value hierarchy as the valuation can be obtained from real time quotes in active markets, and is measured based on Plantify’s closing stock price and prevailing foreign exchange rate at each balance sheet date and the changes in fair value are reflected in gain (loss) on equity investments, net in the consolidated statement of income.
NOTE 3 – INVESTMENT IN NONCONSOLIDATED AFFILIATE (continue)
The fair value of the conversion feature loan was estimated using the Black-Scholes option pricing model with assistance of a third-party appraiser. The assumptions used to perform the calculations are detailed below:
Fair value of the conversion feature as of March 31, 2024 and December 31, 2023:
| Fair value of the conversion feature | March 31, 2024 | December 31, 2023 |
|---|---|---|
| Expected volatility (%) | 148.9% | 135.70% |
| Risk-free interest rate (%) | 4.84% | 5.08% |
| Expected dividend yield | 0.0% | 0.0% |
| Contractual term (years) (*) | 0.5 | 0.25 |
| Conversion price (Canadian dollars) | (US$0.07) C$0.10 | (US$0.04) C$0.054 |
| Underlying share price (Canadian dollars) | (US$0.01) C$0.01 | (US$0.01) C$0.01 |
| Fair value (U.S. dollars) | $1,500 | $900 |
The significant observable inputs used in the fair value measurement of the conversion feature are mainly the expected volatility and risk free interest rate. Significant changes in any of those inputs in isolation would have resulted in a change in the fair value measurement.
The fair value of the debt component of the Debenture was estimated with the assistance of a third-party appraiser by discounting the principal and interest at a discount rate of market interest for similar loans. The interest rate was determined, among other things, based on the potential risk factor of the debt investment in Plantify, at 25.4%.
For the three months ended March 31, 2024, an unrealized gain of $83,943 was recorded in changes in fair value of an investment in an associate measured under the fair value option of comprehensive loss.
The following tables present Plantify’s summarized financial information.
| Revenue | 160,000 |
|---|---|
| Gross loss | (81,000) |
| Net loss | (689,000) |
NOTE 4 –COMMON STOCK
| 1. | On December 22, 2023, the Company entered into a Standby Equity Purchase Agreement (the “SEPA II”) with YA II PN, Ltd. (the “Investor”), pursuant to which the Investor has agreed to purchase up to $20 million shares of common stock over the course of 36 months after the date of the SEPA II. The price of shares to be issued under the SEPA II will be 94% of the lowest volume weighted average trading price (the “VWAP”) of the Company’s common stock for the three consecutive trading days commencing on the delivery of each advance notice by the Company. For additional information, see note 10(21) to the Company’s audited financial statements for the year ended December 31, 2023. |
| The SEPA II will terminate automatically on the earlier of January 1, 2027 or when the Investor has purchased an aggregate of $20 million of the Company’s shares of common stock. The Company has the right to terminate the SEPA II upon five trading days’ prior written notice to the Investor. | |
|---|---|
| In connection with and subject to the satisfaction of certain conditions set forth in the SEPA II, upon the request of the Company, the Investor will pre-advance to the Company up to $3,000,000 of the $20,000,000 commitment amount (See also note 8 below). | |
| The Company paid a subsidiary of the Investor a structuring fee in the amount of $10,000 and on December 28, 2023, the Company issued 110,554 shares of common stock as a commitment fee to a subsidiary of the Investor. The Company determined the value of the shares issued at $254,274 based on the share price on the agreement date, which was recorded as prepaid expenses in other current assets during the year ended December 31, 2023 and $13,463 were recorded during the three months ended March 31, 2024, to the statement of operations under other expenses. | |
| During March 2024, the Company issued 10,000 shares and 18,333 shares of common stock, respectively, to the Investor pursuant to the terms of SEPA II in consideration of $39,950. | |
| 2. | On October 26, 2022, pursuant to an investor relations consulting agreement, the Company’s Board approved the quarterly issuances of 1,286 shares of Common Stock to a consultant beginning in the first quarter of 2023. On March 18, 2024, the Company issued 1,286 shares of common stock to a consultant for consulting services provided to the Company. The shares were estimated at $17,914 based on the share price of the common stock on October 26, 2022. |
| 3. | On March 18, 2024, the Company issued 3,508 shares of common stock to a consultant for consulting services provided to the Company. The Company determined the value of the shares and the services provided at $5,824 and recorded share based compensation expenses. |
| 4. | During the three months ended March 31, 2024, the Company recorded share based compensation expenses in General and Administrative expenses in the amount of $115,814 related to shares issued by the Company to service providers during the year ended December 31, 2023. |
NOTE 5 – STOCK OPTIONS
The following table presents the Company’s stock option activity for employees and directors of the Company for the three months ended March 31, 2024:
| Number of Options | Weighted Average Exercise Price | |
|---|---|---|
| Outstanding at December 31, 2023 | 27,518 | 23.69 |
| Granted | - | - |
| Exercised | - | - |
| Forfeited or expired | - | - |
| Outstanding at March 31, 2024 | 27,518 | 23.69 |
| Number of options exercisable at March 31, 2024 | 27,518 | 23.69 |
The aggregate intrinsic value of the awards outstanding as of March 31, 2024 was $0. These amounts represent the total intrinsic value, based on the Company’s stock price of $1.29 as of March 31, 2024, less the weighted exercise price. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.
Costs incurred in respect of stock-options compensation for employees and directors, for the three months ended March 31, 2024 and 2023 were $0 and $8,460, respectively.
NOTE 6 – RELATED PARTIES
| A. | Transactions and balances with related parties |
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| General and administrative expenses: | ||
| Directors’ compensation | 85,571 | 98,773 |
| Salaries and fees to officers | 127,789 | 137,802 |
| General and administrative expenses net | 213,360 | (*)236,575 |
| (*) of which share based compensation | - | 8,460 |
| Research and development expenses: | ||
| Salaries and fees to officers | - | 23,544 |
| Selling and marketing expenses: | ||
| Salaries and fees to officers | - | 23,544 |
| B. | Balances with related parties and officers: |
| Other accounts payables | 94,442 | 119,793 |
|---|
NOTE 7 – SEGMENT REPORTING
| A. | Information about reported segment profit or loss and assets |
The Company has two reportable segments: (i) Pathogen prevention and prolong shelf life, and (ii) N2O emissions global warming solutions. The Pathogen prevention operating segment consists of Save Foods Ltd. and the global warming solutions operating segment consists of NTWO OFF Ltd.
Information related to the operations of the Company’s reportable operating segments is set forth below:
| Pathogen prevention/ prolong shelf life | Global warming solutions | Total | |
|---|---|---|---|
| Revenues | 43,831 | - | 43,831 |
| Operating loss | (190,783) | (117,939) | (308,722) |
| Unallocated amounts: | |||
| Unallocated costs | (590,344) | ||
| Total operating loss | (899,066) | ||
| Financing income, net | 4,936 | ||
| Other expenses | (12,171) | ||
| Changes in fair value of an investment in an associate measured under the fair value option | 83,943 | ||
| Net loss | (822,358) | ||
| B. | Information on sales by geographic distribution: |
Sales are attributed to geographic distribution based on the location of the customer.
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Israel | 4,856 | 5,221 |
| United States | 38,975 | 41,554 |
| Mexico | - | 73,215 |
| Turkey | - | 1,020 |
| Revenues from sales of products | 43,831 | 121,010 |
| C. | Sales to single customers exceeding 10% of sales (US$): |
| Three months ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Customer A | 38,975 | 41,554 |
| Customer B | - | 73,216 |
| Customer C | 4,856 | - |
| Revenues from sales of products | 43,831 | 114,770 |
| D. | Information on Long-Lived Assets - Property, Plant and Equipment and ROU assets by geographic areas: |
The following table presents the locations of the Company’s long-lived assets as of March 31, 2024 and 2023:
| As of March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Israel | 85,116 | 180,989 |
| United States | 19,082 | 10,218 |
| Property, plant and equipment and ROU assets | 104,198 | 191,207 |
NOTE 8 –SUBSEQUENT EVENTS
| 1. | On April 2, 2024, the Company entered into a binding term sheet with Plantify for a credit facility pursuant to which Plantify may borrow from the Company up to $250,000 at an interest rate of 8% per annum (the “Credit Facility”) for one year. |
| Amounts borrowed from time to time must be repaid within twelve months and any amounts outstanding as of the end of the term must be repaid within ninety days. | |
|---|---|
| During April 2024, Plantify borrowed $106,000 under the Credit Facility. | |
| 2. | On April 4, 2024, the Company, sold a $1,500,000 promissory note (the “Note”) to the Investor pursuant to the terms of SEPA II (See note 4(1) above) in exchange for proceeds of $1,455,000, reflecting an original issue discount of 3% to face value of the Note. |
The Note bears interest at a rate of 8% per annum and matures April 4, 2025. Commencing June 3, 2024, and every 30 days thereafter, the Company is required to pay $150,000, together with accrued and unpaid interest on the then outstanding principal. All payments under the Note may be made either (i) in cash or (ii) by notice of an advance of shares to be issued and sold to the Investor pursuant to the SEPA II, or any combination of (i) or (ii) as determined by the Company. The entire remaining principal balance and unpaid interest amount of the Note becomes due and payable in full at maturity.
The Note sets forth certain events of default, including a breach by the Company of another agreement with the Investor, the failure of the securities of the Company to remain listed on the Nasdaq and the failure of the Company to timely file periodic reports with the SEC. Upon the occurrence of an event of default, interest will accrue at a default rate of 18% per annum and the Note will become immediately due and payable, together with all costs, legal fees and expenses of collection through the date of full repayment.
| 3. | On May 8, 2024, the Company issued 30,000 shares of common stock to a consultant, for services provided to the Company pursuant to an amendment of a consulting agreement, dated November 15, 2023. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.